Close Menu

NEW YORK — Micronoma, a developer of microbiome-based cancer detection technology, said on Thursday that it has raised $3 million in seed funding in a financing round led by SymBiosis.

Micronoma was spun out of the University of California, San Diego in 2019 to commercialize technology based on the discovery that unique microbial DNA signatures in blood and tissue could distinguish healthy individuals from patients with a variety of cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.

Mar
31
Sponsored by
MilliporeSigma

This webinar will outline the development and commercialization journey of a novel CRISPR-based SARS-CoV-2 test.